Insilico Medicine
AI platform for drug discovery using generative AI to design novel molecular structures for clinical development.
- Headquarters
- New York, New York
- Company size
- 201-500 employees
- Founded
- 2014
Product overview
- Target identification and validation
- Clinical trial outcome prediction
- Molecular property optimization
Buyer research
Unlock the full Insilico Medicine profile
Create a free account and complete onboarding for buyer research and procurement details.
Create free accountAlready joined? Log in
Buyer fitUnlock buyer fit
Procurement detailsUnlock procurement details
ImplementationUnlock implementation
IntegrationsUnlock integrations
Customer evidenceUnlock customer evidence
AlternativesUnlock alternatives
VendorUnlock vendor
Is this your product?Claim this profile